Literature DB >> 2468514

Tissue levels and in vivo release of tachykinins and GABA in striatum and substantia nigra of rat brain after unilateral striatal dopamine denervation.

N Lindefors1, E Brodin, U Tossman, J Segovia, U Ungerstedt.   

Abstract

Brain tissue levels and in vivo release of substance P (SP) and neurokinin A (NKA) and GABA were measured bilaterally in striatum and substantia nigra of the rat, after a unilateral 6-hydroxydopamine lesion of the nigro-striatal dopamine pathway. Sham injected animals served as controls. The dopamine denervation decreased the tissue levels of SP in striatum (-38%) ipsilateral to the lesion and in substantia nigra both ipsi- (-54%) and contralateral (-38%) to the lesion. NKA was not significantly changed in the striatum, but decreased (like SP) in the substantia nigra both ipsi- (-50%) and contralateral (-40%) to the lesion. GABA tissue levels increased in the denervated striatum (+20%) and remained unchanged in substantia nigra at both sides. The extracellular levels of SP, NKA and GABA were measured with microdialysis in vivo at basal conditions and during stimulation with potassium administered locally via the microdialysis probe. The stimulated release of SP and NKA in the substantia nigra ipsilateral to the lesion was compared to in sham operated animals reduced with 39% and 64%, respectively, while no change in SP or NKA release was detected in the striatum. The basal release of GABA in the striatum was increased with 296% and with 76% during stimulation in the dopamine denervated striatum, while no change in GABA basal or stimulated release was detected in the substantia nigra. We suggest that the increased GABA release in the dopamine denervated striatum may be due to a decreased dopamine mediated inhibition of local GABA neurons.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2468514     DOI: 10.1007/bf00247354

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  41 in total

1.  Extracellular levels of amino acids in striatum and globus pallidus of 6-hydroxydopamine-lesioned rats measured with microdialysis.

Authors:  U Tossman; J Segovia; U Ungerstedt
Journal:  Acta Physiol Scand       Date:  1986-08

2.  Neurokinin A and substance P in striato-nigral neurons in rat brain.

Authors:  N Lindefors; E Brodin; U Ungerstedt
Journal:  Neuropeptides       Date:  1986 Aug-Sep       Impact factor: 3.286

3.  Microdialysis combined with a sensitive radioimmunoassay. A technique for studying in vivo release of neuropeptides.

Authors:  N Lindefors; E Brodin; U Ungerstedt
Journal:  J Pharmacol Methods       Date:  1987-07

4.  Decrease of substance P-like immunoreactivity in the substantia nigra and pallidum of parkinsonian brains.

Authors:  A Mauborgne; F Javoy-Agid; J C Legrand; Y Agid; F Cesselin
Journal:  Brain Res       Date:  1983-05-23       Impact factor: 3.252

5.  Biphasic and opposite effects of dopamine and apomorphine on endogenous GABA release in the rat substantia nigra.

Authors:  J A van der Heyden; K Venema; J Korf
Journal:  J Neurochem       Date:  1980-01       Impact factor: 5.372

6.  In vivo release of substance P in the cat substantia nigra.

Authors:  R Michelot; V Leviel; Y Torrens; J Glowinski; A Chéramy
Journal:  Neurosci Lett       Date:  1979-12       Impact factor: 3.046

7.  Regional distribution and in vivo release of tachykinin-like immunoreactivities in rat brain: evidence for regional differences in relative proportions of tachykinins.

Authors:  N Lindefors; E Brodin; E Theodorsson-Norheim; U Ungerstedt
Journal:  Regul Pept       Date:  1985-03

8.  Striatal GABAergic neuronal activity is not reduced in Parkinson's disease.

Authors:  T L Perry; F Javoy-Agid; Y Agid; H C Fibiger
Journal:  J Neurochem       Date:  1983-04       Impact factor: 5.372

9.  Calcium-dependent potassium-stimulated release of neurokinin A and neurokinin B from rat brain regions in vitro.

Authors:  N Lindefors; E Brodin; E Theodorsson-Norheim; U Ungerstedt
Journal:  Neuropeptides       Date:  1985-09       Impact factor: 3.286

10.  Regional distribution and extracellular levels of amino acids in rat central nervous system.

Authors:  U Tossman; G Jonsson; U Ungerstedt
Journal:  Acta Physiol Scand       Date:  1986-08
View more
  16 in total

1.  Morphological changes in the rat neostriatum after unilateral 6-hydroxydopamine injections into the nigrostriatal pathway.

Authors:  C A Ingham; S H Hood; B van Maldegem; A Weenink; G W Arbuthnott
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

2.  Control of tachykinin-evoked acetylcholine release from rat striatal slices by dopaminergic neurons.

Authors:  J Alberch; E Arenas; E Pérez-Navarro; J Marsal
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-11       Impact factor: 3.000

Review 3.  Factors regulating the activity of striatal neurons: new perspectives from in situ hybridization histochemistry.

Authors:  B Morris
Journal:  Cell Mol Neurobiol       Date:  1990-03       Impact factor: 5.046

4.  GABAergic inputs from direct and indirect striatal projection neurons onto cholinergic interneurons in the primate putamen.

Authors:  Kalynda Kari Gonzales; Jean-Francois Pare; Thomas Wichmann; Yoland Smith
Journal:  J Comp Neurol       Date:  2013-08-01       Impact factor: 3.215

5.  Region specific regulation of glutamic acid decarboxylase mRNA expression by dopamine neurons in rat brain.

Authors:  N Lindefors; S Brene; M Herrera-Marschitz; H Persson
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

6.  Development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the non-competitive NMDA receptor antagonist, MK-801.

Authors:  J Stewart; J P Druhan
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Modulation of cardiac activity by tachykinins in the rat substantia nigra.

Authors:  A Lessard; R Couture
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

8.  Neuropeptide gene expression in brain is differentially regulated by midbrain dopamine neurons.

Authors:  N Lindefors; S Brené; M Herrera-Marschitz; H Persson
Journal:  Exp Brain Res       Date:  1990       Impact factor: 1.972

9.  Recurrent collateral connections of striatal medium spiny neurons are disrupted in models of Parkinson's disease.

Authors:  Stefano Taverna; Ema Ilijic; D James Surmeier
Journal:  J Neurosci       Date:  2008-05-21       Impact factor: 6.167

10.  Dopamine depletion reorganizes projections from the nucleus accumbens and ventral pallidum that mediate opioid-induced motor activity.

Authors:  L Churchill; M A Klitenick; P W Kalivas
Journal:  J Neurosci       Date:  1998-10-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.